Micro-Randomized Trial to Optimize Digital Oral Health Behavior Change Interventions
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Nov 14, 2022
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
The goal of the MRT is to investigate whether delivering (vs. not delivering) a prompt that contains engagement strategies grounded in decision science is beneficial in terms of promoting proximal oral health behavior (OHB) score, which reflects adherence to the 2x2x4 brushing protocol (Primary Aim) and also mobile health engagement (mHealth; Secondary Aim). Additionally, Exploratory Aims will concern (a) comparing different types of prompts in terms of proximal OHB score and mHealth engagement, (b) investigating the conditions in which prompts should be delivered to most effectively promot...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults, age 18 or older.
- • Fluent in English
- • Dentulous/partially edentulous (18+ teeth; at least 2 teeth in each quadrant)
- • Possess a smartphone (iOS or Android) with a data plan.
- • Willing to allow the passive collection of data on tooth-brushing activities in the home setting for 10 weeks.
- Exclusion Criteria:
- • Not fluent in English
- • Edentulous
- • Unable to use a mobile device due to cognitive or physical impairments
Trial Officials
Vivek Shetty
Principal Investigator
University of California, Los Angeles
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials